Delivery Order SPE2DR25D3003-SPE2DR26F5QM9
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $15,283.96 for 120 tablets of Nubeqa 300 mg on June 18, 2025, with an ultimate completion date of July 11, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $7,280.00 to AmerisourceBergen Drug Corp for the supply of Nubeqa 300 mg tablets (120 count) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $3,836 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Nubeqa 300 mg tablets (120 count). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of December 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,836.00 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Nubeqa 300 mg tablets (120-count units), with an ultimate completion date of January 6, 2026. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $15,283.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Nubeqa 300 mg, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,836.00 to AmerisourceBergen Drug Corp for 120 tablets of Nubeqa 300 mg, an oncology medication used to treat advanced prostate cancer. The contract, which was competitively awarded without set-aside designation, carries a firm fixed price and an ultimate completion date of January 21, 2026. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this award. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 24, 2025, for the supply of Nubeqa 300 mg tablets (120-count units) with a ceiling value of $7,672.00 and an ultimate completion date of January 16, 2026. This is a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a $22,925.94 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Nubeqa 300 mg tablets (120-count units). This is a firm fixed-price, non-set-aside contract with a completion deadline of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nubeqa (darolutamide) is a prostate cancer treatment, reflecting the pharmaceutical distributor's role in supplying specialized oncology...
- The Defense Logistics Agency awarded a delivery order valued at $3,836.00 to AmerisourceBergen Drug Corp for Nubeqa 300 mg tablets (120 count) on November 28, 2025. This is a firm fixed price delivery order with an ultimate completion date of December 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Nubeqa (darolutamide) is an androgen receptor inhibitor used in the treatment...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 120 tablets of Nubeqa 300 mg medication with a ceiling value of $3,836.00. The contract was awarded on December 10, 2025, under firm fixed price terms with an ultimate completion date of January 2, 2026. This is a non-set-aside, competitively awarded delivery order that supports the federal government's pharmaceutical procurement needs for military...